Citation Impact
Citing Papers
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Identification of interferon-stimulated genes that attenuate Ebola virus infection
2020 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Disease-Associated Mutations That Alter the RNA Structural Ensemble
2010
The group II intron ribonucleoprotein precursor is a large, loosely packed structure
2010 StandoutNobel
Mechanisms of Thrombus Formation
2008 Standout
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
2015
Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome
2003
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
2014
Analysis of the effect of aging on the response to hypoxia by cDNA microarray
2003
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Modeling lymphangiogenesis in a three-dimensional culture system
2008
TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction
2004 StandoutNobel
Interaction between the P14 Residue and Strand 2 of β-Sheet B Is Critical for Reactive Center Loop Insertion in Plasminogen Activator Inhibitor-2
2001
Cancer Metastasis: Building a Framework
2006 Standout
The metabolic syndrome
2010 Standout
New Antithrombotic Drugs
2012
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
Thrombin‐activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system
2003
Survey of the year 2004 commercial optical biosensor literature
2005
Antichymotrypsin Interaction with Chymotrypsin
1998
Targeting proteases: successes, failures and future prospects
2006
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
2001
Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease
2015
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The metabolic syndrome
2005 Standout
uPAR: a versatile signalling orchestrator
2002
Survey of the year 2000 commercial optical biosensor literature
2001
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
Glial and neuronal control of brain blood flow
2010 StandoutNature
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Arginine substitutions in the hinge region of antichymotrypsin affect serpin β-sheet rearrangement
1996
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
2015
Crystal Structure of the Complex of Plasminogen Activator Inhibitor 2 with a Peptide Mimicking the Reactive Center Loop
2001
Partitioning of Serpin-Proteinase Reactions between Stable Inhibition and Substrate Cleavage Is Regulated by the Rate of Serpin Reactive Center Loop Insertion into β-Sheet A
2000
Impact of the non‐cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities
2007
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
2004
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
A serpin‐induced extensive proteolytic susceptibility of urokinase‐type plasminogen activator implicates distortion of the proteinase substrate‐binding pocket and oxyanion hole in the serpin inhibitory mechanism
2001
Ulcerative colitis
2016 Standout
Divergent Roles for p55 and p75 TNF-α Receptors in the Induction of Plasminogen Activator Inhibitor-1
2003
Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice
2004
The structure of a serpin–protease complex revealed by intramolecular distance measurements using donor–donor energy migration and mapping of interaction sites
2000
Characterization of a Human α1-Antitrypsin Variant That Is as Stable as Ovalbumin
1998
Survey of the year 2003 commercial optical biosensor literature
2004
Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3)
2000
A survey of the year 2002 commercial optical biosensor literature
2003
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Deep mutational scanning and massively parallel kinetics of plasminogen activator inhibitor-1 functional stability to probe its latency transition
2022
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors
2007
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
2015
Survey of the year 2005 commercial optical biosensor literature
2006
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Formation of the Covalent Chymotrypsin·Antichymotrypsin Complex Involves No Large-scale Movement of the Enzyme
2001
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
2015
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Survey of the year 2001 commercial optical biosensor literature
2002
State of play and clinical prospects of antibody gene transfer
2017
Breast cancer metastasis: markers and models
2005 Standout
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays
2004
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Fibrinogen binds IgG antibody and enhances IgG-mediated phagocytosis1
2008
Serpin Structure, Mechanism, and Function
2002 Standout
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Placental Growth Factor, a Member of the VEGF Family, Contributes to the Development of Choroidal Neovascularization
2003
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Structure of a serpin–protease complex shows inhibition by deformation
2000 Nature
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
BODIPY Dyes and Their Derivatives: Syntheses and Spectroscopic Properties
2007 Standout
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
2008
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Thread-Based Bioluminescent Sensor for Detecting Multiple Antibodies in a Single Drop of Whole Blood
2020
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Structures of Active and Latent PAI-1: A Possible Stabilizing Role for Chloride Ions
2000
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Dual-Color Bioluminescent Sensor Proteins for Therapeutic Drug Monitoring of Antitumor Antibodies
2018
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy
2015
Works of Ann Gils being referenced
Cloning and paratope analysis of an antibody fragment, a rational approach for the design of a PAI‐1 inhibitor
2004
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
2014
Characterization of plasminogen activator inhibitor 1 mutants containing the P13 to P10 region of ovalbumin or antithrombin III: evidence that the P13 residue contributes significantly to the active to substrate transition
1998
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth
2004
Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy
2014
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation
2000
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
2011
Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
2013
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study
2009
Proteinase Specificity and Functional Diversity in Point Mutants of Plasminogen Activator Inhibitor 1
1997
The structural basis for the pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of potential PAI-1 inhibitors
2004
Importance of the Hinge Region between α-Helix F and the Main Part of Serpins, Based upon Identification of the Epitope of Plasminogen Activator Inhibitor Type 1 Neutralizing Antibodies
2000
His374 of wheat endoxylanase inhibitor TAXI‐I stabilizes complex formation with glycoside hydrolase family 11 endoxylanases
2005
Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor
2010
Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differences
2010
Inhibition of plasminogen activator inhibitor‐1: antibody fragments and their unique sequences as a tool for the development of profibrinolytic drugs
2004
Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor
2009
Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1
1997
Fiber optic-SPR platform for fast and sensitive infliximab detection in serum of inflammatory bowel disease patients
2015
Long-Term Outcome of Patients With Crohn’s Disease Who Discontinued Infliximab Therapy Upon Clinical Remission
2014
Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease
2014
The Distal Hinge of the Reactive Site Loop and Its Proximity
2001
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
2015
Characterization and Comparative Evaluation of a Novel PAI-1 Inhibitor
2002
Modulation of Plasminogen Activator Inhibitor 1 by Triton X-100 – Identification of Two Consecutive Conformational Transitions
1998
Substrate Behavior of Plasminogen Activator Inhibitor-1 Is Not Associated with a Lack of Insertion of the Reactive Site Loop
1996
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
2015
The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
2002
Thrombin Activatable Fibrinolysis Inhibitor Activation Peptide Shows Association With All Major Subtypes of Ischemic Stroke and With TAFI Gene Variation
2007
Structure-function relationships in serpins: current concepts and controversies.
1998
Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance Biosensor
2017
Function-Stabilizing Mechanism of Plasminogen Activator Inhibitor Type 1 Induced upon Binding to α1-Acid Glycoprotein
2005
Detection of infliximab levels and anti‐infliximab antibodies: a comparison of three different assays
2012
Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases
2017
Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin
2013
Development of a Genotype 325–Specific proCPU/TAFI ELISA
2003
Elucidation of the Binding Regions of PAI-1 Neutralizing Antibodies Using Chimeric Variants of Human and Rat PAI-1
2001
Evaluation of the mechanism of inactivation of plasminogen activator inhibitor-1 by monoclonal antibodies using a stable variant
1998
Fibrinogen Contains Cryptic PAI-1 Binding Sites That Are Exposed on Binding to Solid Surfaces or Limited Proteolysis
2005